Dimerix Inks Exclusive License Deal With Fuso Pharmaceutical for Kidney Disease Drug Candidate; Shares Soar 23%

MT NewswiresJan 6 20:24 ET

ASX Biggest Gainers

MT NewswiresJan 6 19:38 ET

Guess Which ASX Healthcare Stock Is up 31% on Big News

The Motley FoolJan 6 18:45 ET

Dimerix Completes Part Two of Recruitment for Phase 3 Kidney Disease Trial

MT NewswiresDec 30, 2024 19:45 ET

Dimerix Says Kidney Disease Trial to Continue After Independent Review; Shares Down 3%

MT NewswiresNov 20, 2024 22:14 ET

Companies Like Dimerix (ASX:DXB) Can Afford To Invest In Growth

Yahoo FinanceNov 20, 2024 18:35 ET